Hazlett, Burt & Watson’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.47M Sell
4,137
-90
-2% -$29K 0.38% 67
2026
Q2
$2.04M Sell
4,227
-17
-0.4% -$4.51K 0.54% 44
2026
Q1
$465K Hold
4,244
– – 0.15% 149
2025
Q4
$707K Buy
4,244
+971
+30% +$162K 0.23% 97
2025
Q3
$642K Buy
3,273
+1,525
+87% +$251K 0.23% 102
2025
Q2
$159K Buy
1,748
+863
+98% +$68.2K 0.07% 230
2025
Q1
$53K Buy
885
+835
+1,670% +$77.2K 0.02% 350
2024
Q4
$7K Hold
50
– – ﹤0.01% 592
2024
Q3
$3K Buy
+50
New +$2.35K ﹤0.01% 660

Other funds holding ALAB

Hazlett, Burt & Watson's ALAB Position: Q3 2026 in Review

Hazlett, Burt & Watson reduced its Astera Labs (ALAB) stake by 2.1% in Q3 2026, selling an estimated $29K and leaving 4,137 shares worth $1.47M. The position accounts for 0.38% of the portfolio, ranked #67.

Hazlett, Burt & Watson first reported a position in ALAB in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.04M in Q2 2026. 804 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Hazlett, Burt & Watson held 4,137 shares of Astera Labs worth $1.47M as of Q3 2026.
  • Hazlett, Burt & Watson sold 90 Astera Labs shares in Q3 2026, an estimated $29K.
  • Astera Labs made up 0.38% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #67 holding.
  • Hazlett, Burt & Watson first reported a position in Astera Labs in Q3 2024 and has held it in 9 quarters since.
  • Hazlett, Burt & Watson's Astera Labs position peaked at $2.04M in Q2 2026.
  • 804 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.